arrow
Þ

Þorvarður Jón Löve

Rigshospitalet
H指数:34
被引数:5,512

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Detailed immunophenotypic and genetic characterization of bone marrow clonal plasma cells and B-cells in early-stage monoclonal gammopathies

早期单克隆丙种球蛋白病患者骨髓克隆性浆细胞和B细胞的详细免疫表型及遗传学特征分析

2026-07-180
OA
Psychiatric health of Icelandic adults 40 years or older: A nationwide study of diagnoses, medications, and symptoms

冰岛40岁及以上成年人的精神健康状况:一项关于诊断、药物和症状的全国性研究

2026-04-150
OA
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study

SARS-CoV-2疫苗接种对意义未明的单克隆丙种球蛋白血症的影响:基于人群的iStopMM研究的结果

2026-04-110
OAAI
Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study (vol 52, pg 1098, 2025)

银屑病关节炎患者在使用肿瘤坏死因子抑制剂后抗菌药物使用与严重感染情况:一项全国性匹配队列研究(卷52,页1098,2025)

2026-02-010
PRE
Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study

银屑病关节炎患者应用肿瘤坏死因子抑制剂治疗后抗菌药物与严重感染的关系: 一项全国性匹配队列研究

2025-11-010
PRE
Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study

弥漫性多发性骨髓瘤患者感染风险增加:来自筛查的iStopMM研究的结果

Leukemia
IF13.4
2025-09-120
OAAI
Next-generation flow cytometry analysis of clonal bone marrow plasma cells identifies an indolent subset of MGUS

下一代流式细胞术分析克隆性骨髓浆细胞,识别出一类惰性MGUS亚群

2025-08-210
OAAI
Analysis of smoldering multiple myeloma according to the target of the monoclonal immunoglobulin of patients
2024-12-110
OAAI
Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population-based screening study
2024-11-190
OAAI
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries
2024-08-190
OAAI
Deciphering the genetics and mechanisms of predisposition to multiple myeloma

解读多发性骨髓瘤易感性的遗传学和机制

2024-08-052
OAAI
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - relationship with the reason for withdrawal from the previous treatment
2024-07-011
OAAI
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance
2024-06-180
PRE
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined SignificanceA Cohort Study Nested in a Clinical Trial
2024-04-011
PRE
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network
2024-02-253
OAAI
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naive Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care

在常规护理中使用肿瘤坏死因子抑制剂治疗的12,262生物未接受过治疗的银屑病关节炎患者的患者报告结局 (PROs) 和缓解率

2024-01-150
OA
Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden
2024-01-110
OAAI